{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:49:31Z","timestamp":1793130571170,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1588-0","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T10:54:15Z","timestamp":1519901655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Lucas Souto","family":"Nacif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Waisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Soares","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Roberto","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Rocha-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellington","family":"Andraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Carneiro","family":"D\u2019Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"issue":"4","key":"1588_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ciresp.2017.01.008","volume":"95","author":"AJ Hessheimer","year":"2017","unstructured":"Hessheimer AJ, Nacif L, Flores Villalba E, Fondevila C. Liver transplantation for acute liver failure. Cir Esp. 2017;95(4):181\u20139.","journal-title":"Cir Esp"},{"issue":"11","key":"1588_CR2","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1200\/JCO.2013.50.1320","volume":"34","author":"DJ Harding","year":"2016","unstructured":"Harding DJ, MacQuillan G, Howman R, de Boer B, Adams L, Mitchell A, Jeffrey G. Successful use of dasatinib after liver transplantation for imatinib-induced fulminant liver failure in chronic myeloid leukemia. J Clin Oncol. 2016;34(11):e97\u20138.","journal-title":"J Clin Oncol"},{"key":"1588_CR3","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1182\/blood.V99.6.1928","volume":"99","author":"M Talpaz","year":"2002","unstructured":"Talpaz M, Silver R, Druker B, Goldman J, Gambacorti-Paserini C, Guilhot F, et al. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood. 2002;99:1928\u201337.","journal-title":"Blood"},{"key":"1588_CR4","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2003-07-2323","volume":"102","author":"N Lin","year":"2003","unstructured":"Lin N, Sarantopoulos S, Stone J, Gallinsky I, Stone R, Deangelo D, et al. Fatal hepatic necrosis following imatinib mesylate therapy. Blood. 2003;102:3455\u20136.","journal-title":"Blood"},{"key":"1588_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ajh.20486","volume":"81","author":"T Cross","year":"2006","unstructured":"Cross T, Bagot C, Portmann WJ, Gillet D. Imatinib mesylate as a cause of acute liver failure. Am J Hematol. 2006;81:189\u201392.","journal-title":"Am J Hematol"},{"key":"1588_CR6","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.3748\/wjg.v13.i48.6608","volume":"13","author":"E Ridruejo","year":"2007","unstructured":"Ridruejo E, Cacchione R, Villamil AG, Marciano S, Gadano AC, Mand\u00f3 OG. Imatinib-induced fatal acute liver failure. World J Gastroenterol. 2007;13:6608\u201311.","journal-title":"World J Gastroenterol"},{"key":"1588_CR7","first-page":"e86","volume":"49","author":"TJK Thia","year":"2008","unstructured":"Thia TJK, Tan HH, Chuah THC, Chow WC, Lui HF. Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection. Singap Med J. 2008;49:e86\u20139.","journal-title":"Singap Med J"},{"key":"1588_CR8","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1016\/j.leukres.2009.06.012","volume":"33","author":"G Perini","year":"2009","unstructured":"Perini G, Santos F, Funke V, Ruiz J, Ferraz B, Hamerschlak N. Nilotinib post-liver transplantation for acute hepatic failure related to imatinib. Leuk Res. 2009;33:e234\u20135.","journal-title":"Leuk Res"},{"issue":"7","key":"1588_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.medcli.2010.09.011","volume":"137","author":"C Mart\u00ednez Pascual","year":"2011","unstructured":"Mart\u00ednez Pascual C, Vald\u00e9s Mas M, de la Pe\u00f1a Moral JM, Miras L\u00f3pez M. Fulminating hepatitis for imatinib in a patient with chronic myeloid leukaemia [in Spanish]. Med Clin (Barc). 2011;137(7):329\u201330.","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"1588_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s12032-009-9284-y","volume":"27","author":"O Tonyali","year":"2010","unstructured":"Tonyali O, Coskun U, Yildiz R, Karakan T, Demirci U, Akyurek N, Benekli M, Buyukberber S. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors. Med Oncol. 2010;27(3):768\u201373.","journal-title":"Med Oncol"},{"issue":"4","key":"1588_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1345\/aph.1L528","volume":"43","author":"AM Weise","year":"2009","unstructured":"Weise AM, Liu CY, Shields AF. Fatal liver failure in a patient on acetaminophen treated with sunitinib malate and levothyroxine. Ann Pharmacother. 2009;43(4):761\u20136.","journal-title":"Ann Pharmacother"},{"issue":"7","key":"1588_CR12","first-page":"4037","volume":"35","author":"T Akamine","year":"2015","unstructured":"Akamine T, Ando K, Oki E, Saeki H, Nakashima Y, Imamura YU, Ohgaki K, Maehara Y. Acute liver failure due to regorafenib may be caused by impaired liver blood flow: a case report. Anticancer Res. 2015;35(7):4037\u201341.","journal-title":"Anticancer Res"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1588-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T00:07:31Z","timestamp":1552176451000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1588-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1588-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,10]]},"assertion":[{"value":"8 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. No writing assistance was used in the production of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"63"}}